A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaMaria Domenica Cappellini, Antonio Piga, Vip Viprakasit et al.|New England Journal of Medicine|2020Cited by 320
PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In VivoHye-Jung Ihn, Eui Kyun Park, Jin‐Woo Park et al.|International Journal of Molecular Sciences|2021Cited by 12
Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorptionSoo-min Lim, Eui Kyun Park|Animal Cells and Systems|2023Cited by 3